Obesity
Conditions
Interventions
Exposed group:acupoint catgut embedding combined with basic lifestyle management
Non-exposed group:Non-acupoint embedding combined with basic lifestyle management
Sponsors
Dongfang Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) Aged 18–60 years; 2) Meeting the diagnostic criteria for mild to moderate obesity; 3) If currently undergoing any weight loss intervention (including pharmacotherapy), must have completely discontinued such intervention for at least 2 weeks; 4) Willing to participate voluntarily and provide signed informed consent.
Exclusion criteria
Exclusion criteria: 1) Pregnant or lactating women; 2) Patients with severe diseases involving the heart, liver, kidneys, blood system, endocrine system, etc., or those with secondary obesity; 3) Obesity caused by medication use; 4) Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels > 1.5 times the upper limit of normal (ULN), or serum creatinine (Cr) level above the ULN; 5) Participation in another clinical trial within the past 3 months or current participation in any other clinical trial; 6) Any other conditions deemed by the investigator as inappropriate for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in body fat percentage; | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in body mass index (BMI);Change in waist circumference;Change in visceral fat area;Change in basal metabolic rate (BMR);Proportion of clinically diagnosed type 2 diabetes or prediabetes;Change in blood glucose;Change in glycated hemoglobin;Change in total cholesterol;Change in triglycerides;Change in high-density lipoprotein cholesterol (HDL-C); | — |
Countries
China
Contacts
Public ContactJiang Min
Dongfang Hospital, Beijing University of Chinese Medicine
Outcome results
None listed